Samir Darwish

Plasma DNA, Microsatellite Alterations, and p53 Tumor Mutations Are Associated with Disease-Free Survival in Radically Resected Non-small Cell Lung Cancer Patients: A Study of the Perugia Multidisciplinary Team for Thoracic Oncology

Vienna Ludovini, Lorenza Pistola, Vanesa Gregorc et al. · Journal of Thoracic Oncology · 2008 · 76 citations · Full text

Plasma Dna, Perugia Multidisciplinary Team, Medicine +8

Short-Course Palliative Radiotherapy in Non–Small-Cell Lung Cancer

Marco Lupattelli, Ernesto Maranzano, Rita Bellavita et al. · American Journal of Clinical Oncology · 2000 · 52 citations

A randomized trial of three cisplatin-containing regimens in advanced non-small-cell lung cancer (NSCLC): a study of the Umbrian Lung Cancer Group

Lucio Crinò, Maurizio Tonato, Samir Darwish et al. · Cancer Chemotherapy and Pharmacology · 1990 · 51 citations

Cisplatin-containing Regimens, Medicine, Bronchial Neoplasm +7

Biological prognostic factors for early stage completely resected non-small cell lung cancer

Lucio Cagini, Massimo Monacelli, Giammario Giustozzi et al. · Journal of Surgical Oncology · 2000 · 49 citations

Vascular endothelial growth factor, p53, Rb, Bcl-2 expression and response to chemotherapy in advanced non-small cell lung cancer

Vienna Ludovini, Vanesa Gregorc, Lorenza Pistola et al. · Lung Cancer · 2004 · 48 citations

Oncology, Medicine, Immunology +9